224 related articles for article (PubMed ID: 11280804)
41. The expression and action of granulocyte macrophage-colony stimulating factor and its interaction with TGF-beta in endometrial carcinoma.
Ripley D; Tang XM; Ma C; Chegini N
Gynecol Oncol; 2001 May; 81(2):301-9. PubMed ID: 11330966
[TBL] [Abstract][Full Text] [Related]
42. Neutrophils contribute to the measles virus-induced antitumor effect: enhancement by granulocyte macrophage colony-stimulating factor expression.
Grote D; Cattaneo R; Fielding AK
Cancer Res; 2003 Oct; 63(19):6463-8. PubMed ID: 14559838
[TBL] [Abstract][Full Text] [Related]
43. Protein kinase Cdelta-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression.
Wheeler DL; Reddig PJ; Dreckschmidt NE; Leitges M; Verma AK
Oncogene; 2002 May; 21(22):3620-30. PubMed ID: 12032864
[TBL] [Abstract][Full Text] [Related]
44. Keratinocyte-derived granulocyte-macrophage colony stimulating factor accelerates wound healing: Stimulation of keratinocyte proliferation, granulation tissue formation, and vascularization.
Mann A; Breuhahn K; Schirmacher P; Blessing M
J Invest Dermatol; 2001 Dec; 117(6):1382-90. PubMed ID: 11886498
[TBL] [Abstract][Full Text] [Related]
45. Granulocyte-macrophage colony-stimulating factor (GM-CSF) is expressed in mouse skin in response to tumor-promoting agents and modulates dermal inflammation and epidermal dark cell numbers.
Vasunia KB; Miller ML; Puga A; Baxter CS
Carcinogenesis; 1994 Apr; 15(4):653-60. PubMed ID: 8149476
[TBL] [Abstract][Full Text] [Related]
46. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
[TBL] [Abstract][Full Text] [Related]
47. Metallothionein deficiency enhances skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate in metallothionein-null mice.
Suzuki JS; Nishimura N; Zhang B; Nakatsuru Y; Kobayashi S; Satoh M; Tohyama C
Carcinogenesis; 2003 Jun; 24(6):1123-32. PubMed ID: 12807749
[TBL] [Abstract][Full Text] [Related]
48. Increased skin carcinogenesis in a keratinocyte directed thioredoxin-1 transgenic mouse.
Mustacich D; Wagner A; Williams R; Bair W; Barbercheck L; Stratton SP; Bhattacharyya AK; Powis G
Carcinogenesis; 2004 Oct; 25(10):1983-9. PubMed ID: 15166090
[TBL] [Abstract][Full Text] [Related]
49. Overexpression of bone morphogenetic protein-6 (BMP-6) in murine epidermis suppresses skin tumor formation by induction of apoptosis and downregulation of fos/jun family members.
Wach S; Schirmacher P; Protschka M; Blessing M
Oncogene; 2001 Nov; 20(53):7761-9. PubMed ID: 11753654
[TBL] [Abstract][Full Text] [Related]
50. Selective up-regulation of macrophage function in granulocyte-macrophage colony-stimulating factor transgenic mice.
Elliott MJ; Strasser A; Metcalf D
J Immunol; 1991 Nov; 147(9):2957-63. PubMed ID: 1655901
[TBL] [Abstract][Full Text] [Related]
51. Granulocyte-macrophage colony-stimulating factor-producing tumour vaccines.
Rössner P; Bubeník J; Sobota V; Indrová M; Hájková R; Mendoza L; Jandlová T; Símová J
Folia Biol (Praha); 1999; 45(5):173-7. PubMed ID: 10730885
[TBL] [Abstract][Full Text] [Related]
52. Cyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor development.
Bol DK; Rowley RB; Ho CP; Pilz B; Dell J; Swerdel M; Kiguchi K; Muga S; Klein R; Fischer SM
Cancer Res; 2002 May; 62(9):2516-21. PubMed ID: 11980643
[TBL] [Abstract][Full Text] [Related]
53. Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin.
Guo H; Miao H; Gerber L; Singh J; Denning MF; Gilliam AC; Wang B
Cancer Res; 2006 Jul; 66(14):7050-8. PubMed ID: 16849550
[TBL] [Abstract][Full Text] [Related]
54. Dendritic cells genetically engineered to simultaneously express endogenous tumor antigen and granulocyte macrophage colony-stimulating factor elicit potent therapeutic antitumor immunity.
Nakamura M; Iwahashi M; Nakamori M; Ueda K; Matsuura I; Noguchi K; Yamaue H
Clin Cancer Res; 2002 Aug; 8(8):2742-9. PubMed ID: 12171908
[TBL] [Abstract][Full Text] [Related]
55. The designer cytokine hyper-IL-6 mediates growth inhibition and GM-CSF-dependent rejection of B16 melanoma cells.
Ozbek S; Peters M; Breuhahn K; Mann A; Blessing M; Fischer M; Schirmacher P; Mackiewicz A; Rose-John S
Oncogene; 2001 Feb; 20(8):972-9. PubMed ID: 11314032
[TBL] [Abstract][Full Text] [Related]
56. Anti-tumor effect of in vivo IL-2 and GM-CSF electrogene therapy in murine hepatoma model.
Chi CH; Wang YS; Lai YS; Chi KH
Anticancer Res; 2003; 23(1A):315-21. PubMed ID: 12680230
[TBL] [Abstract][Full Text] [Related]
57. Mechanisms contributing to the sex difference in levels of granulocyte-macrophage colony-stimulating factor in the urine of GM-CSF transgenic mice.
Metcalf D
Exp Hematol; 1988 Oct; 16(9):794-800. PubMed ID: 3049131
[TBL] [Abstract][Full Text] [Related]
58. [A correlation between the abilities of tumor cells to produce GM-CSF and form metastasis].
Kumagai K; Hatakeyama K; Takeda K; Tsuchiya Y; Rikiishi H
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3367-73. PubMed ID: 2679394
[TBL] [Abstract][Full Text] [Related]
59. Targeted expression of c-Src in epidermal basal cells leads to enhanced skin tumor promotion, malignant progression, and metastasis.
Matsumoto T; Jiang J; Kiguchi K; Ruffino L; Carbajal S; Beltrán L; Bol DK; Rosenberg MP; DiGiovanni J
Cancer Res; 2003 Aug; 63(16):4819-28. PubMed ID: 12941801
[TBL] [Abstract][Full Text] [Related]
60. Impaired in vivo tumor growth of human pancreatic carcinoma cells retrovirally transduced with GM-CSF gene.
Kimura M; Tagawa M; Yoshida Y; Takenouchi T; Takenaga K; Azuma K; Yamaguchi T; Saisho H; Sakiyama S
Anticancer Res; 1998; 18(1A):165-70. PubMed ID: 9568072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
